Getnet M Assefa

📣 A quick reminder that our 3‑day Fundamentals of Population Pharmacokinetics workshop is coming up! Whether you’re stepping into PK for the first time or refreshing your understanding, you’ll get guided, practical experience with real datasets and model‑building workflows. 📅 15–17 July 2026 📍 UQ Brisbane City 💲AUD 650 We’ll cover key PK principles, PopPK basics, dataset construction, model development, validation, and Monte Carlo simulations — all in a supportive, beginner‑friendly environment. 🎟️ Registration and details: bit.ly/4rKjd9L

BLING III is changing clinical practice guidelines!!! Great work👍

Worth reading!! doi.org/10.1093/jac/dk…

Highly recommended PK workshop!!

The AMR Action Subcommittee and Study Group for Artificial intelligence and Digitalisation (ESGAID) recently published a perspective on the implications of using AI in the fight against #AMR. Check it out: ow.ly/Bbwm50YeZTF

Worth attending!

Super interesting! 🆕💫Keeping the horse *with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales #IDXposts journals.asm.org/doi/10.1128/aa…

🙌We are proud to introduce CRE RESPOND's final seminar of the year as part of the Education Program 2025!🙌 We're thrilled to announce that the UTI Guidelines: Clinical practice guidelines on prevention and management of Urinary Tract Infections (UTIs) seminar will take place on: 📅Thursday 20th November, 12pm-1pm AEST At the: 📍Auditorium of the UQ Centre for Clinical Research Our speakers include guideline authors and committee members who will present on the newly published clinical practice guidelines for UTI's📖 Register here: bit.ly/48ZZgoE #CRERESPOND #UQCCR #UTI #Guidelines #Infections #Prevention #Management #UrinaryTract

Super interesting! 🆕💫Comparative in vitro activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant Pseudomonas aeruginosa #idxposts The punch effect! academic.oup.com/jac/article-ab…

New RCT from @UQMedicine Cefiderocol versus standard therapy for healthcare-associated Gram-negative BSI @UQ_GAMECHANGER @UQ_News >500 patients in 6 countries with high rates of MDR; 25% carb-R; Non-inferior but not superior for 14d mortality @TheLancetInfDis @davidantibiotic

🤩The third instalment of the CRE RESPOND quarterly newsletter will be sent out tomorrow!🤩 📣 Our newsletter lets you stay informed on our talented and dedicated team of researchers and their current projects and publications, as well as our visitors who come from all over the world to work with us. If you want to learn all about the team and the amazing work they do, our newsletter is the best place to find all that information in one go! Subscribe here: bit.ly/4enYORH In advance of its release tomorrow, here's a little sneak peak of what you can expect... 🤫

Honoured to receive the HDR Award Winner recognition at the Herston Health Precinct Symposium 2025. I am grateful to my supervisors, @b_fekade and @jasonroberts_pk, for their invaluable support. #HHPS2025, @CRE_RESPOND, #UQCCR, @UQMedicine, @UQ_News

💥 BIG problems need BIG solutions Drug resistance is putting lives at risk worldwide. That’s why we’re launching #ThisIsBig—a bold campaign calling for greater investment and collaboration to develop new antibiotics and expand access to treatment 🚀 📢 Share the video. Join the movement. 🔗 gardp.org/this-is-big

Our article: doi.org/10.1093/jac/dk…… has been selected for inclusion in the Best of Journal of Antimicrobial Chemotherapy 2024. @b_fekade @jasonroberts_pk @CRE_RESPOND #UQCCR @UQMedicine @UQ_News academic.oup.com/jac/pages/best…

SO excited to officially announce the 2024 Pharmacy to Dose Award winners! 🎉 🍾 Research article of the year: Jason Roberts @jasonroberts_pk Non-research article of the year : Mojdeh Heavner @HeavnerPharmD Preceptor of the Year: Grace Benanti Mentor of the Year: Brian Gilbert @GilbertPharmD Conference Speaker of the Year: Gretchen Sacha @gretchensacha Unsung Hero award: Caitlin Brown @CBthePHARMD Tag Team Tandem Award: Kat Spezzano and Christian Kressin @KatSpazPharmD @CKressinPharmD People’s Choice Award: Andy Webb @AJWPharm Black Cloud award: Haley Peters MVP: Anthony Hawkins @iamahawkins Living Legend award: Nicole Acquisto Thank you so much everyone for voting!! Full awards episode coming very soon 👀 👏🏻

🌟NEW in IJAA🌟 Authors find #OPAT is a safe and effective alternative to inpatient IV #antimicrobial treatment in this systematic review & meta-analysis which includes >1,300 patients. Read the open access article⬇️ tinyurl.com/43jmdc3c

🆕️🔥State of the art review article #JAC 🌟s @jasonroberts_pk @b_fekade @MGilchrist123 Current Practices and challenges of outpatient parenteral antimicrobial therapy #OPAT #IDXposts #bookmark Great tables🎯 academic.oup.com/jac/article/do…

Well done Mikaela, excellent talk!

Congratulations 🎆🎆 @Sai_Naicker

Risk scoring tools for early prediction of CRE BSIs have limitations and lack of external validity outside the local setting in which they were developed: doi.org/10.1093/jacamr… @OUPMedicine @OxfordJournals #JACAMRNews